Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
Diabetes care, 2016-12, Vol.39 (12), p.e212-e213 [Peer Reviewed Journal]ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-1312 ;PMID: 27679584
Full text available